Most of us are well-versed in how lipid dysfunction, e.g., cholesterol, is a primary driver for heart attacks. We also know that hypertension, or high blood pressure, leads to heart disease.
They both also put you at risk for new-onset atrial fibrillation (AFib).
Lipid Dysfunction and AFib
At first glance, cholesterol and atrial fibrillation (AFib) seem like they should move in the same direction. High cholesterol is a well-known risk factor for heart attacks and stroke. But when it comes to AFib, the relationship is more complicated and somewhat counterintuitive.
A large nationwide cohort study published in the Journal of the American Heart Association found what researchers call the “cholesterol paradox.” In simple terms, lower total cholesterol and LDL (“bad”) cholesterol levels were associated with a higher risk of developing AFib. At the same time, greater variability in cholesterol levels – meaning cholesterol that fluctuates significantly from visit to visit – was also linked to increased AFib risk.1
So, what might explain this?
Several mechanisms are proposed:
- Cell membrane stability – Cholesterol is a structural component of cell membranes; we actually need cholesterol. It helps regulate membrane fluidity (how flexible or stable a cell’s outer layer is). When cholesterol levels are low, membranes may become more fluid, which can alter the function of ion channels (the microscopic gates that control electrical signals in heart cells). Since AFib is fundamentally an electrical disorder of the heart, even small changes in electrical stability can increase arrhythmia risk.
- Inflammation – Chronic inflammation (persistent immune activation) is strongly associated with AFib development. During inflammatory states, total cholesterol, LDL, and HDL levels often drop, while triglycerides may rise. Low cholesterol, therefore, may sometimes act as a marker of underlying inflammation rather than a direct cause of AFib.
- Hormonal and metabolic influences – Conditions such as hyperthyroidism (overactive thyroid) lower cholesterol levels and independently increase AFib risk. In older adults, cholesterol levels also naturally decline while AFib risk rises, which may contribute to the observed association.
Perhaps even more important than cholesterol levels alone is cholesterol variability. The same study found that fluctuations in total cholesterol, LDL, and HDL were independently associated with higher AFib risk. In other words, instability in lipid levels may reflect broader metabolic instability – and the heart does not respond well to instability.
It is important to note that this does not mean high cholesterol is protective overall. Elevated lipids remain a major risk factor for coronary artery disease and stroke. However, when specifically examining AFib, both low cholesterol levels and significant lipid swings appear linked to increased risk.
Hypertension and AFib
Unlike the nuanced lipid story, the connection between hypertension and AFib is strong, consistent, and well supported.
Individuals with hypertension have about a 50% higher relative risk of developing AFib compared to those with normal blood pressure. Furthermore, risk rises progressively as blood pressure increases.2
To break it down:
- For every 20-point increase in systolic blood pressure (the top number), AFib risk increased by about 19%.
- For every 10-point increase in diastolic blood pressure (the bottom number), risk increased by about 6%.
- At very high levels (around 180/110), AFib risk was roughly two times higher than at 90/60.
Why does this happen?
High blood pressure places chronic mechanical stress on the heart. Over time, that pressure causes:
- Left ventricular hypertrophy (thickening of the heart’s main pumping chamber)
- Atrial enlargement (stretching and expansion of the upper chambers)
- Fibrosis (scar tissue formation)
- Inflammation and cell death (apoptosis) within the heart muscle
As the atria stretch and stiffen, their electrical signaling becomes disorganized. AFib is essentially chaotic electrical activity in the atria. Structural remodeling (physical changes in heart tissue) combined with electrical instability creates the perfect environment for arrhythmia to develop.
Additionally, hypertension activates the renin–angiotensin–aldosterone system (RAAS), a hormone system that regulates blood pressure and fluid balance. Chronic activation contributes to fibrosis and autonomic nervous system imbalance, both of which further promote AFib.
In short, high blood pressure physically reshapes the heart in ways that make AFib more likely.
Double-Whammy
In some populations, both unmanaged lipid dysfunction and hypertension occur together, which can lead to major malfunction within the cardiovascular system – it becomes a synergistic spiral.
Hypertension mechanically stresses the heart, which, if unmanaged, can lead to structural remodeling. In other words, it can cause the heart muscle to thicken, enlarge, and develop fibrosis. Lipid dysregulation can indicate broader metabolic dysfunction that destabilizes cellular function and amplifies inflammation.
Chronic inflammation could be the common thread linking the two. Hypertension promotes inflammatory signaling, and lipid abnormalities are associated with inflammatory states as well. Persistent inflammation drives fibrosis, atrial enlargement, and electrical disruption. Over time, the atria become both structurally remodeled and electrically unstable.
This “double-whammy” increases:
- the risk of AFib onset
- the likelihood of persistent (rather than intermittent) AFib
- the risk of stroke (due to clot formation in poorly contracting atria)
- and overall cardiovascular strain
This is the take-home message: when blood pressure is uncontrolled and lipid metabolism is unstable, the cardiovascular system is forced to compensate on multiple fronts, and that compensation often fails in the form of arrhythmia.
From a prevention standpoint, maintaining steady lipid levels and aggressively managing blood pressure may be critical strategies for reducing AFib risk. Stability, in this context, matters just as much as absolute numbers.
Dr. Andrea Tordini is a board-certified cardiac electrophysiologist with advanced training in diagnosing and treating heart rhythm disorders. She specializes in managing fast and slow heart rhythms using pacemakers, ICDs (implantable defibrillators), and minimally invasive ablation procedures.
Dr. Tordini is a part of Florida Medical Clinic Orlando Health
- Lee, H., Lee, S., Choi, E., Han, K., & Oh, S. (2019). Low Lipid Levels and High Variability are Associated With the Risk of New‐Onset Atrial Fibrillation. Journal of the American Heart Association, 8(23). https://doi.org/10.1161/jaha.119.012771.
- Aune, D., Mahamat-Saleh, Y., Kobeissi, E., Feng, T., Heath, A. K., & Janszky, I. (2023). Blood pressure, hypertension and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. European journal of epidemiology, 38(2), 145–178. https://doi.org/10.1007/s10654-022-00914-0.
